[Inhibition of intestinal absorption as a principle of the treatment of metabolic diseases].
Frol'kis
A V
AV
D000818:Animals; D000924:Anticholesteremic Agents / Q000494:pharmacology / Q000627:therapeutic use; D001645:Biguanides / Q000494:pharmacology / Q000627:therapeutic use; D003676:Deferoxamine / Q000494:pharmacology / Q000627:therapeutic use; D004285:Dogs; D006801:Humans; D007408:Intestinal Absorption / Q000187:drug effects*; D008031:Lignin / Q000494:pharmacology / Q000627:therapeutic use; D008659:Metabolic Diseases / Q000188:drug therapy*; D051379:Mice; D011299:Prenylamine / Q000494:pharmacology / Q000627:therapeutic use; D051381:Rats
D000924:Anticholesteremic Agents; D001645:Biguanides; D008031:Lignin; D003676:Deferoxamine; D011299:Prenylamine
Tormozhenie kishechnogo vsasyvaniia kak printsip lecheniia obmennykh zabolevaniĭ.